Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ensembling noisy segmentation masks of blurred sperm images.
Lewandowska E, Węsierski D, Mazur-Milecka M, Liss J, Jezierska A. Lewandowska E, et al. Among authors: liss j. Comput Biol Med. 2023 Sep 22;166:107520. doi: 10.1016/j.compbiomed.2023.107520. Online ahead of print. Comput Biol Med. 2023. PMID: 37804777 Free article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Robust Vocal Quality Feature Embeddings for Dysphonic Voice Detection.
Zhang J, Liss J, Jayasuriya S, Berisha V. Zhang J, et al. Among authors: liss j. IEEE/ACM Trans Audio Speech Lang Process. 2023;31:1348-1359. doi: 10.1109/taslp.2023.3261753. Epub 2023 Mar 28. IEEE/ACM Trans Audio Speech Lang Process. 2023. PMID: 37899766 Free PMC article.
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
A speech-based prognostic model for dysarthria progression in ALS.
Stegmann G, Charles S, Liss J, Shefner J, Rutkove S, Berisha V. Stegmann G, et al. Among authors: liss j. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Jun 12:1-6. doi: 10.1080/21678421.2023.2222144. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 37309077
245 results